Inherited thrombophilia and pregnancy: A case control study on sicilian population;Trombofilia ereditaria e complicanze gravidiche nella popolazione siciliana

Italian Journal of Gynaecology and Obstetrics

Volumn 21, Issue 3, 2009, Pages 129-136

  Bertolino, W O ^a   Labate, F ^a   Bertolino, E C ^a   Rannazzisi, M ^a   Assadi, G ^a   Sammarco, P ^a   Niceta, M ^a   Fabiano, C ^a  

^a AOV Cervello   (Italy)

Author keywords

DIC; Fetal growth restriction; Intrauterine death; Placenta abruption; Preeclampsia; Pregnancy; Thrombophilia; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; LOW MOLECULAR WEIGHT HEPARIN;

ADULT; ANAMNESIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; ITALY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION BASED CASE CONTROL STUDY; PREGNANCY; PREGNANCY COMPLICATION; RISK ASSESSMENT; THROMBOPHILIA;

EID: 71749119049     PISSN: 11218339     EISSN: 23850868     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Paidas MJ, Ku DH, Arkel YS. Screening and management of inherited thrombophilias in the setting of adverse pregnancy outcome. Clin. Perinatol 31:783-805, 2004. (Pubitemid 39425110)
2. Dahlback B. Inherited resistance to activated protein C, a major cause of venous thrombosis, is due to a mutation in the factor V gene. Haemostasis 24:139-151, 1994. (Pubitemid 24234492)
3. Greer IA.Epidemiology, risk factors and prophylaxis of venous thromboembolism in obstetrics and gynecology. Clin Obstet Gynecol. 11:403-430, 1997. (Pubitemid 27470549)
4. Greer IA. Thrombosis in pregnancy: maternal and fetal issues. Lancet 353:1258-1265, 1999. (Pubitemid 29168473)
5. Lindqvist P, Dahlback B, Marsal K. Thrombotic risk during pregnancy: a population study. Obstet Gynecol 94:595-599, 1999. (Pubitemid 29460947)
6. Andersen BS, Steffensen FH, Sorensen HT, et al. The cumulative incidence of venous thromboembolism during pregnancy and puerperium. Acta Obstet Gynecol Scand 77:170-173, 1998.
7. Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 12:141-154, 1981. (Pubitemid 11150978)
8. Stirling Y, Woolf L, North WR, et al. Haemostasis in normal pregnancy. Thromb Haemost 52:176-182, 1984.
9. Comp PC, Thurnau GR, Welsh J, et al: Functional and immunologic protein S levels are decreased during pregnancy. Blood 68:881-885,1986. (Pubitemid 17183847)
10. Cumming AM, Tait RC, Fildes S, et al. Development of resistance to activated protein C during pregnancy. Br J Haematol 90:725-727,1995.
11. Bremme KA. Hemostatic changes in pregnancy. Baillieres Best Pract Res Clin Haematol 16:153-168, 2003
12. Ku DH, Arkel YS, Paidas MP, et al: Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90:1074-1079, 2003.
13. Bremme K, Ostlund E, Almqvist I, et al. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 80:132-137, 1992.
14. Dahlback B. Protein S and C4b-binding protein: components involved in the regulation of the protein C anticoagulant pathway. Thromb Haemost 66:49-61, 1991.
15. Mosnier LO, Meijers JCM, Bouma BN.The role of protein S in the activation of TAFI and regulation of fibrinolysis. Thromb Haemost. 86:1035-1039, 2001.
16. Dykes AC, Walker ID, McMahon AD, et al. A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency state. Br J Haematol 113:636, 2001.
17. Sugimura M, Kobayashi T, Kanayama N, et al. Detection of decreased response to activated protein C during pregnancy by an endogenous thrombin potential-based assay. Semin Thromb Hemost 25:497-502, 1999. (Pubitemid 30010807)
18. Prager NA, Abendschein DR, McKenzie CR, et al. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots. Circulation 92:962-996, 1995.
19. Paidas MJ, Ku DW, Lee MJ, et al. Protein Z, protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 3:497-501, 2005.
20. Paidas M, Ku DW, Arkel Y, et al. Normal pregnancy is associated with the development of Protein S and Protein Z antibodies, independent of PS and PZ level. Am J Obstet Gynecol 191:S491, 2004.
21. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Zdependent protease inhibitor. Blood 96:3049-3055, 2000. (Pubitemid 30815212)
22. Kemkes-Matthes B, Matthes KJ.Protein Z. Seminars Thromb Hemost 5:551-556, 2001.
23. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 86:8-13, 2001.
24. Broze GJ Jr. Protein-Z and thrombosis. Lancet 357:933-934, 2001.
25. Han X, Huang ZF, Fiehler R, et al. The protein Z-dependent protease inhibitor is a serpin. Biochemistry 38:11073-11078, 1999. (Pubitemid 29411597)
26. Yurdakok M, Gurakan B, Ozbag E, et al. Plasma protein Z levels in healthy newborn infants. Am J Hematol 48:206-207, 1995.
27. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 69:1580-1586,1987.
28. Kemkes-Matthes B, Nees M, Kuhnel G, et al. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 106:183-185, 2002. (Pubitemid 35248049)
29. McColl MD, Deans A, Maclean P, et al. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. Br J Haematol 120:913-914, 2003. (Pubitemid 36315122)
30. Steffano B, Forastiero R, Martinuzzo M, et al. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 12:411-412, 2001. (Pubitemid 32730502)
31. Gamba G, Bertolino G, Montani N, et al. Bleeding tendency of unknown origin and protein Z levels. Thromb Res 90:291-295, 1998. (Pubitemid 28383790)
32. Wuillemin WA, Demarmels Biasiutti F, Mattle HP, et al. Frequency of PZ deficiency in patients with ischemic stroke. Lancet 358:840-841,2001. (Pubitemid 32868744)
33. Gris JC, Quere I, Dechaud H, et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 99:2606-2608, 2002. (Pubitemid 34525453)
34. Gris JC, Mercier E, Quere II, et al. Low-molecular- weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder. Blood 103:3695-3699, 2004. (Pubitemid 38596284)
35. Gris JC, Amadio C, Mercier E, et al. Antiprotein Z antibodies in women with pathologic pregnancies. Blood 101:4850-4852, 2003. (Pubitemid 36857746)
36. Lockwood CJ. Inherited thrombophilias in pregnant patients: detection and treatment paradigm. Obstet Gynecol 99:333-341, 2002.
37. Girling J, de Swiet M.Inherited thrombophilia and pregnancy. Curr Opin Obstet Gynecol 10:135-144, 1998
38. Preston FE, Rosendaal FR, Walker ID, et al. Increased fetal loss in women with heritable thrombophilia. Lancet 348:913-916, 1996.
39. Kupferminc MJ, Eldor A, Steinman N, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 340:9, 1999. (Pubitemid 29024678)
40. Alfirevic Z. How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J. Obstet Gynecol Reprod Biol 101:6-14, 2002. (Pubitemid 34142238)
41. Dahlback D, Stenflo J. A natural anticoagulant pathway: proteins C, S, C4b-binding protein and thrombomodulin, in Bloom AL, Forbes CD, Thomas DP, Tuddenham GD (eds): Haemostasis and Thrombosis. New York, NY, Churchill Livingstone, 1994, pp 671-698.
42. Rey E, Kahn SR, David M, et al. Thrombophilic disorders and fetal loss: a meta- analysis. Lancet 361:901-908, 2003 (Pubitemid 36335814)
43. Ridker PM, Miletich JP, Hennekens CH, et al. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. J Am Med Assoc 277:1305-1307, 1997.
44. Lockwood CJ: Inherited thrombophilias in pregnant patients. Prenat Neonat Med 6:3-14, 2001.
45. Voorberg J, Roeise J, Koopman R, et al. Association of idiopathic venous thromboembolism with single point-mutation at Arg 506 of factor V. Lancet 343:1535-1536, 1994. (Pubitemid 24180051)
46. Poort SR.A common genetic variation in the 3=-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703, 1996.
47. Gerhardt A, Eberhard Scharf R, Wilhelm Beckmann M, et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium. N. Engl J Med 342:374-380, 2000. (Pubitemid 30084535)
48. Hunt LT, Dayhoff MO. A surprising new protein superfamily containing ovalbumin, antithrombin- III, and alpha-1 proteinase inhibitor. Biochem Biophys Res Comm 95:864-871, 1980.
49. Gettins P, Patson DP, Schapira M. Structure and mechanism of action of serpins. Hematol Oncol Clin North Am 6:1393-1418, 1992.
50. Andreasen PA, Georg B, Lund LR, et al.Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 68:1-19,1990. (Pubitemid 20015463)
51. Kruithof EKO, Tran-Thang C, Gudinchet A, et al. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 69:460-466, 1987. (Pubitemid 17022014)
52. Riyazi N, Leeda M, de Vries JI, et al. Low-molecular- weight heparin combined with aspirin in pregnant women with thrombophilia and a history of preeclampsia or fetal growth restriction: a preliminary study. Eur J Obstet Gynecol Reprod Biol 80:49-54, 1998. (Pubitemid 29272019)
53. Paidas M, Ku DH, Triche E, et al. Does heparin therapy improve pregnancy outcome in patients with thrombophilias? J Thromb Haemost, 2:1194-1195, 2004.
54. Walker MC: Heparin for pregnant women with acquired or inherited thrombophilias. Cochrane Database Syst Rev 2:CD003580, 2003.
55. Brenner B, Hoffman R, Carp H, et al. Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study. J Thromb Haemost 3:227-229, 2005. (Pubitemid 41623606)
56. Kupferminc MJ, Fait G, Many A, et al. Severe preeclampsia. High frequency of genetic thrombophilic mutations. Obstet Gynecol 96:45-49, 2000.
57. Faccinetti F. Thrombophilic mutations are a main risk factor for placental abruption. Haemotologica 88:785-788, 2003.
58. Martinelli I. Familiar thrombophilia and the occurrence of fetal growth restriction. Haematologica 86:428-431, 2001 (Pubitemid 32428505)
59. Kupferminc MJ. Mid-trimester severe intrauterine growth restriction is associated with a high prevalence of thrombophilia. Br J Obstet Gynaecol 109:1373-1376, 2002.
60. Paidas MJ et al. Prchal JT, Tricot GJ (eds). Hematology 2003. Washington, DC, American Society of Hematology, 2003, pp 503-509.
61. Bertolino OW, Lo Bue V, Lionti F, Miceli V, Quartararo P. Trombofilia e gravidanza. Aggiornamenti di Ostetricia e Ginecologia. COFESE edizioni, 2003.
62. Bertolino OW, Lo Bue V, Quartararo O. La Malattia Tromboembolica in Gravidanza. Aggiornamenti di Ostetricia e Ginecologia. COFESE edizioni, Luglio 2001.
63. Bertolino OW,Lo Bue V, La Giglia E, Aliotta G, Lionti F, Quartararo P. Trombofilia e gravidanza la nostra esperienza. Contraccezione,Fertilità, Sessualità. COFESE edizioni, Luglio 2003.
64. Kupferminc M, Fait G, Many A, et al. Low molecular weight heparin for the prevention of obstetric complications in women with thrombophilia. Hypertens Pregnancy 20:35-44, 2001. (Pubitemid 32672926)
65. Grandone E. Preventing adverse obstetric outcomes in women with genetic thrombophilia. Fertil Steril 78:371-375, 2002. (Pubitemid 34831739)
66. Brenner B. Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin. Thromb Haemost 83:693-697, 2000. (Pubitemid 30248516)
67. Ogueh O: Outcome of pregnancy in women with hereditary thrombophilia. Int J Gynaecol Obstet 74:247-253, 2001. (Pubitemid 32785659)